Back to search
FDAFDA · Food and drugs·Recall number D-0366-2024

Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01

Published March 13, 2024 · Recall initiated: February 20, 2024

Summary

FDA records drug Class II recall D-0366-2024, published March 13, 2024 and initiated February 20, 2024. Recalling firm: Eugia US LLC; Status: Ongoing; Reported quantity: 10,080 vials; Lot: Lot #: 3MA23001, 3MA23002, 3MA23003, Exp 3/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if METHYLPREDNISOLONE ACETATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
METHYLPREDNISOLONE ACETATE
Manufacturer
Eugia US LLC
Distributor
OH, TN, LA, MS
UPC
0355150313013
Lot
Lot #: 3MA23001, 3MA23002, 3MA23003, Exp 3/31/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01 recalled?

Yes. FDA published recall D-0366-2024 on March 13, 2024. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: METHYLPREDNISOLONE ACETATE. UPC: 0355150313013.